Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 49.23 +0.91 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.32 | 52 Week High | $0.15 | |||
| Open | $49.57 | 52 Week Low | $0.15 | |||
| Day High | $49.69 | P/E | N/A | |||
| Day Low | $48.19 | EPS | $0.00 | |||
| Volume | 139,518 | |||||
